- Home
- SKX vs LNTH Comparison
SKX vs LNTH Comparison
Compare SKX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- LNTH
- Stock Information
- Founded
- SKX 1992
- LNTH 1956
- Country
- SKX United States
- LNTH United States
- Employees
- SKX N/A
- LNTH N/A
- Industry
- SKX Shoe Manufacturing
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SKX Consumer Discretionary
- LNTH Health Care
- Exchange
- SKX Nasdaq
- LNTH Nasdaq
- Market Cap
- SKX 6.9B
- LNTH 7.5B
- IPO Year
- SKX 1999
- LNTH 2015
- Fundamental
- Price
- SKX $62.24
- LNTH $78.95
- Analyst Decision
- SKX Buy
- LNTH Strong Buy
- Analyst Count
- SKX 13
- LNTH 5
- Target Price
- SKX $70.33
- LNTH $133.80
- AVG Volume (30 Days)
- SKX 11.3M
- LNTH 1.3M
- Earning Date
- SKX 04-24-2025
- LNTH 05-07-2025
- Dividend Yield
- SKX N/A
- LNTH N/A
- EPS Growth
- SKX 9.64
- LNTH N/A
- EPS
- SKX 4.16
- LNTH 3.53
- Revenue
- SKX $9,129,335,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- SKX $9.70
- LNTH $5.81
- Revenue Next Year
- SKX $8.17
- LNTH $12.26
- P/E Ratio
- SKX $14.96
- LNTH $22.69
- Revenue Growth
- SKX 10.66
- LNTH 12.53
- 52 Week Low
- SKX $44.50
- LNTH $74.34
- 52 Week High
- SKX $78.85
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- SKX 69.31
- LNTH 27.93
- Support Level
- SKX $46.74
- LNTH $78.61
- Resistance Level
- SKX $61.70
- LNTH $83.60
- Average True Range (ATR)
- SKX 1.06
- LNTH 3.87
- MACD
- SKX 1.69
- LNTH -3.13
- Stochastic Oscillator
- SKX 98.36
- LNTH 1.12
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.